0.10Open0.10Pre Close0 Volume73 Open Interest10.00Strike Price0.00Turnover904.87%IV383.25%PremiumJan 17, 2025Expiry Date0.00Intrinsic Value100Multiplier4DDays to Expiry0.10Extrinsic Value100Contract SizeAmericanOptions Type0.1382Delta0.1068Gamma20.90Leverage Ratio-0.0477Theta0.0000Rho2.89Eff Leverage0.0005Vega
IGM Biosciences Stock Discussion
IGM Biosciences to Halt Development of Imvotamab, Cut 73% of Staff
ROKU: 26% cash, $487 million in Silicon Valley Bank. $Roku Inc (ROKU.US)$
BLOCKFI: According to a bankruptcy filing, BlockFi has $227 million in "unprotected" funds at Silicon Valley Bank, possibly in violation of U.S. bankruptcy law.
RBLX: Roblox says 5% of its $3 billion cash and securities balance is held by S...
• $MillerKnoll (MLKN.US)$ +12.4%, $BioNTech (BNTX.US)$ +7.4%, $Lululemon Athletica (LULU.US)$ +6.5% (also authorizes $1 bln stock repurchase program)
• $Adagio Therapeutics (ADGI.US)$ +52.47% (announces ADG20 (adintrevimab) is the first monoclonal antibody to meet primary endpoints with statistical significance across pre- and post-exposure prophylaxis and treatment for COVID-19 and plans to seek US emergency use authorization)
...
$Greenlane (GNLN.US)$
No comment yet